| Year |
Citation |
Score |
| 2020 |
Yin H, Zhu J, Wang M, Yao ZP, Lubman DM. The Quantitative Analysis of Alpha-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS. Analytical Chemistry. PMID 32426967 DOI: 10.1021/Acs.Analchem.0C00420 |
0.65 |
|
| 2019 |
Liang J, Zhu J, Wang M, Singal AG, Odewole M, Kagan S, Renteria V, Liu S, Parikh ND, Lubman DM. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies. Scientific Reports. 9: 11580. PMID 31399619 DOI: 10.1038/S41598-019-48043-1 |
0.674 |
|
| 2018 |
Wang M, Zhu J, Lubman DM, Gao C. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. Clinical Chemistry and Laboratory Medicine. PMID 30138110 DOI: 10.1515/Cclm-2018-0379 |
0.652 |
|
| 2018 |
Wang M, Gao Y, Feng H, Warner E, An M, Jia J, Chen S, Fang M, Ji J, Gu X, Gao C. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Cancer Medicine. PMID 29473340 DOI: 10.1002/cam4.1341 |
0.648 |
|
| 2017 |
Wang M, Fang M, Zhu J, Feng H, Warner E, Yi C, Ji J, Gu X, Gao C. Serum N-glycans outperform CA19-9 in diagnosis of extrahepatic cholangiocarcinoma. Electrophoresis. PMID 28752594 DOI: 10.1002/Elps.201700084 |
0.476 |
|
| 2012 |
Neubert H, Fountain S, King L, Clark T, Weng Y, O'Hara DM, Li W, Leung S, Ray C, Palandra J, Ocaña MF, Chen J, Ji C, Wang M, Long K, et al. Tissue bioanalysis of biotherapeutics and drug targets to support PK/PD. Bioanalysis. 4: 2589-604. PMID 23173794 DOI: 10.4155/bio.12.234 |
0.663 |
|
| Show low-probability matches. |